Pharma-Bio Serv, Inc.
General ticker "PBSV" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $12.5M (TTM average)
Pharma-Bio Serv, Inc. follows the US Stock Market performance with the rate: 36.9%.
Estimated limits based on current volatility of 3.0%: low 0.55$, high 0.58$
Factors to consider:
- Company pays dividends (annually): last record date 2025-02-28, amount 0.07$ (Y12.96%)
- Total employees count: 75 (-25.0%) as of 2024
- Top business risk factors: Economic downturns and volatility, Operational and conduct risks, Fixed costs, Cybersecurity threats, IT system disruptions
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-10-31 to 2026-10-31
- 2024-10-31 to 2025-10-31 estimated range: [0.43$, 0.92$]
- 2025-10-31 to 2026-10-31 estimated range: [0.45$, 0.96$]
Financial Metrics affecting the PBSV estimates:
- Positive: with PPE of -20.5 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -4.11 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term PBSV quotes
Long-term PBSV plot with estimates
Financial data
| YTD | 2022-10-31 | 2023-10-31 | 2024-10-31 |
|---|---|---|---|
| Operating Revenue | $19.40MM | $16.98MM | $9.51MM |
| Operating Expenses | $18.22MM | $15.86MM | $10.80MM |
| Operating Income | $1.17MM | $1.12MM | $-1.29MM |
| Non-Operating Income | $0.01MM | $0.57MM | $0.53MM |
| Income(Loss) | $1.19MM | $1.69MM | $-0.76MM |
| Taxes | $0.18MM | $0.38MM | $0.02MM |
| Profit(Loss)* | $1.01MM | $1.31MM | $-0.78MM |
| Stockholders Equity | $16.56MM | $16.13MM | $13.72MM |
| Assets | $20.65MM | $19.90MM | $16.29MM |
| Operating Cash Flow | $0.59MM | $1.89MM | $-0.57MM |
| Capital expenditure | $0.02MM | $0.01MM | $0.16MM |
| Investing Cash Flow | $-0.02MM | $-4.22MM | $-1.36MM |
| Financing Cash Flow | $-3.53MM | $-1.76MM | $-1.73MM |
| Earnings Per Share** | $0.04 | $0.06 | $-0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.